Figure 2.
Sunitinib (red line) versus interferon-α (IFN, black line) study progression-free survival curves for first-line renal cell cancer [Motzer et al. 2007]. With permission, New England Medical Society. CI, confidence interval.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.